News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
397,658 Results
Type
Article (32029)
Company Profile (58)
Press Release (365571)
Multimedia
Podcasts (41)
Webinars (5)
Section
Business (112824)
Career Advice (1323)
Deals (24049)
Drug Delivery (94)
Drug Development (59726)
Employer Resources (104)
FDA (9953)
Job Trends (9087)
News (211575)
Policy (25532)
Tag
2024 BioCapital Digital (1)
2024 BioMidwest Digital (1)
2024 Bio NC Digital (1)
2024 Bio NC Standard (1)
2024 Biotech Bay Standard (4)
2024 Biotech Beach Digital (1)
2024 Biotech Beach Standard (4)
2024 Genetown Digital (1)
2024 Genetown Standard (5)
2024 Lone Star Bio Digital (4)
2024 Pharm Country Digital (1)
2024 Pharm Country Standard (1)
2025 Lone Star Bio Digital (1)
2026 BioCapital Standard (1)
2026 Bio NC Standard (1)
2026 Genetown Standard (1)
2026 Pharm Country Premier (1)
2026 Pharm Country Standard (1)
Academia (1842)
Accelerated approval (4)
Adcomms (20)
Allergies (66)
Alliances (42277)
ALS (58)
Alzheimer's disease (1107)
Antibody-drug conjugate (ADC) (93)
Approvals (9948)
Artificial intelligence (157)
Autoimmune disease (16)
Automation (6)
Bankruptcy (237)
Best Places to Work (7694)
BIOSECURE Act (16)
Biosimilars (82)
Biotechnology (42)
Bladder cancer (48)
Brain cancer (27)
Breast cancer (187)
Cancer (1580)
Cardiovascular disease (127)
Career advice (1113)
Career pathing (19)
CAR-T (105)
Cell therapy (292)
Cervical cancer (16)
Clinical research (48213)
Collaboration (668)
Compensation (428)
Complete response letters (19)
COVID-19 (2476)
CRISPR (30)
C-suite (111)
Cystic fibrosis (58)
Data (1494)
Decentralized trials (1)
Denatured (9)
Depression (35)
Diabetes (215)
Diagnostics (3571)
Digital health (10)
Diversity (4)
Diversity, equity & inclusion (33)
Drug discovery (86)
Drug pricing (96)
Drug shortages (28)
Duchenne muscular dystrophy (82)
Earnings (40354)
Editorial (36)
Employer branding (13)
Employer resources (94)
Events (45759)
Executive appointments (316)
FDA (10792)
Featured Employer (18)
Fibrodysplasia Ossificans Progressiva (1)
Friedreich's ataxia (2)
Frontotemporal dementia (5)
Funding (469)
Gene editing (73)
Generative AI (13)
Gene therapy (229)
GLP-1 (691)
Government (4098)
Grass and pollen (4)
Guidances (34)
Healthcare (11414)
Huntington's disease (19)
IgA nephropathy (21)
Immunology and inflammation (86)
Indications (22)
Infectious disease (2615)
Inflammatory bowel disease (76)
Inflation Reduction Act (7)
Influenza (51)
Intellectual property (70)
Interviews (231)
IPO (10442)
IRA (40)
Job creations (1747)
Job search strategy (956)
Kidney cancer (7)
Labor market (16)
Layoffs (278)
Leadership (9)
Legal (7059)
Liver cancer (51)
Lung cancer (230)
Lymphoma (106)
Machine learning (5)
Management (32)
Manufacturing (219)
MASH (54)
Medical device (5922)
Medtech (5923)
Mergers & acquisitions (14014)
Metabolic disorders (591)
Multiple sclerosis (52)
NASH (20)
Neurodegenerative disease (68)
Neuropsychiatric disorders (24)
Neuroscience (1491)
NextGen: Class of 2025 (3657)
Non-profit (2769)
Northern California (1611)
Now hiring (4)
Obesity (338)
Opinion (194)
Ovarian cancer (53)
Pain (48)
Pancreatic cancer (65)
Parkinson's disease (113)
Partnered (13)
Patents (161)
Patient recruitment (58)
Peanut (38)
People (24868)
Pharmaceutical (18)
Pharmacy benefit managers (10)
Phase I (14567)
Phase II (20937)
Phase III (16997)
Pipeline (876)
Policy (127)
Postmarket research (1846)
Preclinical (6031)
Press Release (28)
Prostate cancer (77)
Psychedelics (28)
Radiopharmaceuticals (205)
Rare diseases (267)
Real estate (2581)
Recruiting (44)
Regulatory (16134)
Reports (22)
Research institute (1592)
Resumes & cover letters (195)
Rett syndrome (3)
RNA editing (3)
RSV (47)
Schizophrenia (60)
Series A (77)
Series B (40)
Service/supplier (4)
Sickle cell disease (38)
Southern California (1316)
Special edition (5)
Spinal muscular atrophy (137)
Sponsored (18)
Startups (1885)
State (1)
Stomach cancer (11)
Supply chain (54)
Tariffs (23)
The Weekly (31)
United States (13131)
Vaccines (703)
Venture capitalists (27)
Weight loss (248)
Women's health (13)
Worklife (10)
Date
Today (75)
Last 7 days (270)
Last 30 days (1577)
Last 365 days (21039)
2025 (6152)
2024 (22366)
2023 (25267)
2022 (33395)
2021 (35891)
2020 (34071)
2019 (27908)
2018 (21234)
2017 (20187)
2016 (18692)
2015 (21494)
2014 (15948)
2013 (12876)
2012 (13623)
2011 (14401)
2010 (13078)
Location
Africa (570)
Alabama (30)
Alaska (3)
Arizona (90)
Arkansas (5)
Asia (25917)
Australia (4677)
California (3515)
Canada (1200)
China (351)
Colorado (151)
Connecticut (156)
Delaware (97)
Europe (62142)
Florida (535)
Georgia (125)
Hawaii (1)
Idaho (28)
Illinois (286)
India (22)
Indiana (189)
Iowa (7)
Japan (117)
Kansas (61)
Kentucky (15)
Louisiana (9)
Maine (28)
Maryland (638)
Massachusetts (2539)
Michigan (101)
Minnesota (139)
Mississippi (1)
Missouri (49)
Montana (20)
Nebraska (10)
Nevada (36)
New Hampshire (20)
New Jersey (1123)
New Mexico (15)
New York (1071)
North Carolina (502)
North Dakota (4)
Northern California (1611)
Ohio (111)
Oklahoma (6)
Oregon (10)
Pennsylvania (772)
Puerto Rico (5)
Rhode Island (13)
South America (797)
South Carolina (11)
South Dakota (1)
Southern California (1316)
Tennessee (52)
Texas (436)
Utah (78)
Virginia (90)
Washington D.C. (36)
Washington State (301)
West Virginia (2)
Wisconsin (27)
397,658 Results for "biofrontera ag".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Genetown
Biofrontera Inc. Announces Restructuring of Supply Agreement with Biofrontera AG
Biofrontera Inc. today announced the restructuring of agreements between the Company and its former parent company Biofrontera AG.
February 20, 2024
·
5 min read
Press Releases
Biofrontera Inc. to Report Fourth Quarter and Full Year 2024 Financial Results on March 21, 2025
March 12, 2025
·
1 min read
Genetown
Biofrontera Announces the Launch of a New, FDA-Approved Red Light Source, the RhodoLED® XL Lamp
Biofrontera Inc. (NASDAQ: BFRI), a biopharmaceutical company specializing in the commercialization of dermatologic products, is proud to announce the launch of its FDA-approved RhodoLED XL, a red light emitting LED lamp.
June 24, 2024
·
5 min read
Press Releases
Biofrontera Inc. Announces 100 RhodoLED® XL Machines Now Placed in US Market
December 23, 2024
·
5 min read
Business
Biofrontera Inc. Reports First Quarter 2024 Financial Results and Provides a Business Update
Biofrontera Inc., a biopharmaceutical company specializing in the commercialization of dermatologic products, reported financial results for the three months ended March 31, 2024 and provided a business update.
May 15, 2024
·
11 min read
Press Releases
Biofrontera Inc. Closes a $4.2 Million Senior Secured Convertible Note
November 25, 2024
·
3 min read
Regulatory
FDA Action Alert: Biofrontera, BMS and Zealand
One upcoming decision—on a perioperative PD-1 regimen for lung cancer—comes as the FDA considers an overhaul of trial designs in this treatment setting.
September 30, 2024
·
4 min read
·
Tristan Manalac
Deals
Biofrontera Inc. Enters into Agreements to Purchase Options of Biofrontera AG
Biofrontera Inc. announced today it has entered into private exchange agreements with certain holders of options to acquire ordinary shares of Biofrontera AG.
October 31, 2022
·
5 min read
Press Releases
Biofrontera Inc. to Present at The Benchmark Company’s Upcoming Discovery One-on-One Investor Conference
December 3, 2024
·
4 min read
Business
Biofrontera Inc. to Report First Quarter 2024 Financial Results on May 15, 2024
Biofrontera Inc. (NASDAQ:BFRI), a biopharmaceutical company specializing in the commercialization of dermatological products, today announced that it will report financial results for the three months ended March 29, 2024 on Wednesday, May 15, 2024.
May 6, 2024
·
1 min read
1 of 39,766
Next
